Market Research Future has added a report titled “Vaccine Adjuvants Market Research
Report - Global forecast till 2023” to its offering.
Market Synopsis of the Global Vaccine Adjuvants Market
Vaccine adjuvant is an immunological agent that modifies the effect of other agents. It is
added to vaccine in order to enhance the immune response and to provide long-lasting
protection against antigen. Aluminum hydroxide and paraffin oil are most commonly used
adjuvants. Governments’ initiatives for vaccinations, high prevalence of infectious and
zoonotic diseases, and growing focus on improved and long-lasting immunization against
existing and emerging diseases are major driving forces for the growth of the market.
Moreover, increasing investments by companies in research and development, increasing
focus on immunization programs, and increasing demand for vaccines are fueling to the
market growth. Additionally, increasing prevalence of the diseases in children and rising
number of awareness programs to promote vaccination are expected to drive the growth of
this market over the forecast period. However, high toxicity of adjuvants, and cost of
developing a new vaccine adjuvants may hamper the growth of the market.
Get Premium Sample Copy @
https://www.marketresearchfuture.com/sample_request/1098
The Global Vaccines Adjuvants Market is expected to grow at a healthy CAGR of 10.1%
during the forecast period 2017-2023.
Key Players in the Global Vaccine Adjuvants Market:
Some of the key players in this market are VaxLiant LLC.(U.S),Vaxine Pty Ltd (Australia),
Aphios Corporation (U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants
(U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector
(Denmark), CSL Limited (Australia), SEPPIC (Fracne), Agenus, Inc. (U.S), Novavax,
Inc.(U.S), SPI Pharma, Inc.(U.S), Invivogen (U.S), Avanti Polar Lipids, Inc. (U.S), MPV
Technologies (U.S), and OZ Biosciences (France).
Segments:
The global vaccine adjuvants are segmented by types, routes of administration, and end
users.
On the basis of types, it is segmented into pathogen components, particulate adjuvants,
and others.
On the basis of routes of administration, it is segmented into oral, intramuscular,
subcutaneous, and intradermal.
On the basis of end users, it is segmented into pediatric, adult.
Regional Analysis of the Global Vaccine Adjuvants Market:
The global market is segmented into the Americas, Europe, Asia Pacific, and the Middle East